Lower Serum Levels of Antibodies against Tetanus Toxin in Patients with Hypothyroidism
Authors
Abstract:
Background: A fundamental duty of the immune system is to defend against infectious agents. Significant abnormalities were reported in immune parameters of hypothyroid and hyperthyroid patients. In this study, we aim to assess various quantities of antibodies against the tetanus toxin (anti-TT) in hypothyroid and hyperthyroid patients. Materials and Methods: Anti-TT levels were measured in serum samples from 50 hypothyroid patients, 50 hyperthyroid patients, and 50 euthyroid individuals, using the ELISA method. Besides, the minimum protective quantity of anti-TT was considered 0.1 IU/mL. Results: Seroprotective rates against tetanus were 100, 80, and 96.0 % in euthyroid, hypothyroid, and hyperthyroid groups with the means of 3.52 ± 0.31, 1.62 ± 0.21, and 4.07 ± 0.32 IU/ml, respectively. Accordingly, hypothyroid patients exhibited lower anti-TT levels and seroprotective rates than the euthyroid group (P < 0.001 and P<0.004, respectively). Besides, in the hypothyroid group, anti-TT quantities and seroprotective rates were lower than those in hyperthyroid individuals (P < 0.001 and P < 0.03, respectively). Conclusions: The findings demonstrated lower immunity and higher susceptibility to tetanus in patients with hypothyroidism. However, more studies are needed to be conducted in this field to provide more data to be considered in health programs.
similar resources
Lower serum level of anti-tetanus toxin antibodies in patients with type 2 diabetes mellitus.
AIM To evaluate the serum levels of anti-tetanus toxin antibodies (anti-TTA) in patients with type 2 diabetes mellitus (DM) and in a control group. METHODS Totally, 100 patients with type 2 DM and 100 age- and sex-matched healthy individuals were enrolled to study. The presence of type 2 DM confirmed according to the clinical and para-clinical criteria such as fasting plasma glucose above 126...
full textStudy of serum levels of antibodies against Helicobacter pylori in patients of Islamshahr Health Center in Tehran
Background and Goals: Helicobacter pylori is a gram-negative micro-aerophilic bacillus, with a global prevalence. The bacterium causes a wide range of gastrointestinal diseases, including chronic gastritis, peptic ulcer, gastric cancer and MALT. Due to the importance of this bacterium in causing gastrointestinal disorders, this study was conducted to evaluate the serum levels of antibodies agai...
full textHybridomas Producing Monoclonal Antibodies against Tetanus Toxin Replaces the Polyclonal Horse Anti-Tetanic Serum
Two toxic substances are produced, a hemolysin (Tetanolysine) and the potent lethal toxin (Tetanospasmin or Neurotoxin). The former is responsible for areas of hemolysis around colonies on blood agar plates. Neurotoxin is highly toxic when injected parentrally; however, it is harmless if administered by mouth. Animals vary in their susceptibility to tetanus toxin, e.g., horse and man are the mo...
full textLower immunity to tetanus in cigarette smoker subjects
Background: Cigarette smoking has been linked with the suppression of immune responses and increased susceptibility to numerous infections in humans. Tetanus is also a major public health problem in many countries. The aim of the present study was to evaluate the serum levels of anti-tetanus toxin antibodies in c igarette smoking and healthy non-smoking people . Materials and M...
full textToxin-neutralizing effect of antibody against subtilisin-digested tetanus toxin.
A form of systemic tetanus with atypical symptoms was observed in mice injected in the left thigh with a mixture of tetanus toxin and antibody produced in guinea pigs against a fragment of toxin obtained from a subtilisin digest of the crystallized toxin. The mice did not show typical symptoms of the local tetanus such as convulsions or spastic paralysis of the injected limb.
full textMy Resources
Journal title
volume 10 issue 3
pages 134- 139
publication date 2021-07
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023